EichorEICHOR
Location: Gloucester Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Gloucester

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
Phase 3 · Gloucestershire Royal Hospital · Boehringer Ingelheim · NCT06531824
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · Addison Gilbert Hospital · NRG Oncology · NCT05174169
Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Canc
Phase 3 · Addison Gilbert Hospital · Alliance for Clinical Trials in Oncology · NCT06632327
E-Mindfulness Approaches for Living After Breast Cancer
Phase 3 · Addison Gilbert Hospital · NRG Oncology · NCT06748222
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-S
Phase 3 · Addison Gilbert Hospital · National Cancer Institute (NCI) · NCT06498635
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectab
Phase 2 · Addison Gilbert Hospital · NRG Oncology · NCT05327686
The Early Valve Replacement in Severe ASYmptomatic Aortic Stenosis Study
NA · Gloucestershire Hospitals NHS Foundation · University of Leicester · NCT04204915
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide,
Phase 3 · Addison Gilbert Hospital · National Cancer Institute (NCI) · NCT06058377
An Internet-based Program to Help Cancer Survivors Manage Pain
NA · Peninsula Cancer Institute - Gloucester · Wake Forest University Health Sciences · NCT04462302
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Remo
Phase 2/Phase 3 · Addison Gilbert Hospital · National Cancer Institute (NCI) · NCT05987241
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
Phase 3 · Peninsula Cancer Institute-Gloucester · Alliance for Clinical Trials in Oncology · NCT05008848
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had
Phase 2/Phase 3 · Addison Gilbert Hospital · SWOG Cancer Research Network · NCT06616584
A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema
Phase 2 · Gloucestershire Royal Hospital · Boehringer Ingelheim · NCT06962839
Anti-vascular Endothelial Growth Factor (Anti-VEGF) Monotherapy vs Anti-VEGF Followed by Subthreshold Micropulse Laser f
Phase 3 · Gloucestershire Royal Hospital · Belfast Health and Social Care Trust · NCT06985706
Randomised Evaluation of Sodium Dialysate Levels on Vascular Events
Phase 4 · Cotswold Dialysis Centre · University of Sydney · NCT02823821
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung
Phase 3 · Addison Gilbert Hospital · National Cancer Institute (NCI) · NCT04267848
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Phase 2/Phase 3 · Addison Gilbert Hospital · SWOG Cancer Research Network · NCT03851445
WithHolding Enteral Feeds Around Blood Transfusion (International)
NA · Gloucestershire Hospitals NHS Foundation Trust (Gloucestersh · IWK Health Centre · NCT05213806
A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA)
Phase N/A · Gloucestershire Royal Hospital · Complement Therapeutics · NCT07144137
Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer
Phase 3 · Addison Gilbert Hospital · Canadian Cancer Trials Group · NCT06205485
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Phase 3 · Addison Gilbert Hospital · National Cancer Institute (NCI) · NCT04181060
Study to Investigate the Efficacy, Safety and Durability of Faricimab in Caucasian Patients With Polypoidal Choroidal Va
Phase 4 · Clinical Trial Unit, Dep. Ophth., Gloucestershire Hospitals · Association for Innovation and Biomedical Research on Light · NCT06709339
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-M
Phase 2 · Addison Gilbert Hospital · SWOG Cancer Research Network · NCT06116682
Hydrolysed Rice Formula Study
NA · Gloucestershire Royal NHS Trust · Nutricia UK Ltd · NCT06288503
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
Phase 3 · Gloucester Royal Hospital · UMC Utrecht · NCT02735707
A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Sever
Phase 3 · Gloucestershire Royal Hospital /ID# 257953 · AbbVie · NCT06012240
A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and N
Phase 3 · GSK Investigational Site · GlaxoSmithKline · NCT06256588
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Phase N/A · Addison Gilbert Hospital · SWOG Cancer Research Network · NCT04871542
Optimisation of the Blood Culture Pathway Utilising Behaviour Change
Phase N/A · Gloucestershire Royal Hospital · Gloucestershire Hospitals NHS Foundation Trust · NCT07392684
A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma
Phase 3 · Gloucestershire Royal Hospital · Takeda · NCT06980480
Look up another city
Look up another condition